Publication Date:
2018-03-06
Description:
SHP2 inhibition restores sensitivity in ALK -rearranged non-small-cell lung cancer resistant to ALK inhibitors SHP2 inhibition restores sensitivity in 〈i〉ALK〈/i〉-rearranged non-small-cell lung cancer resistant to ALK inhibitors, Published online: 05 March 2018; doi:10.1038/nm.4497 Genomic and drug screens identify SHP2 blockade as a therapeutic approach for ALK-rearranged non-small cell lung cancers developing resistance through ALK-mutant-independent mechanisms.
Print ISSN:
1078-8956
Electronic ISSN:
1546-170X
Topics:
Biology
,
Medicine